318 related articles for article (PubMed ID: 19373782)
1. Array comparative genomic hybridization identifies a distinct DNA copy number profile in renal cell cancer associated with hereditary leiomyomatosis and renal cell cancer.
Koski TA; Lehtonen HJ; Jee KJ; Ninomiya S; Joosse SA; Vahteristo P; Kiuru M; Karhu A; Sammalkorpi H; Vanharanta S; Lehtonen R; Edgren H; Nederlof PM; Hietala M; Aittomäki K; Herva R; Knuutila S; Aaltonen LA; Launonen V
Genes Chromosomes Cancer; 2009 Jul; 48(7):544-51. PubMed ID: 19373782
[TBL] [Abstract][Full Text] [Related]
2. Mutation screening of fumarate hydratase by multiplex ligation-dependent probe amplification: detection of exonic deletion in a patient with leiomyomatosis and renal cell cancer.
Ahvenainen T; Lehtonen HJ; Lehtonen R; Vahteristo P; Aittomäki K; Baynam G; Dommering C; Eng C; Gruber SB; Grönberg H; Harvima R; Herva R; Hietala M; Kujala M; Kääriäinen H; Sunde L; Vierimaa O; Pollard PJ; Tomlinson IP; Björck E; Aaltonen LA; Launonen V
Cancer Genet Cytogenet; 2008 Jun; 183(2):83-8. PubMed ID: 18503824
[TBL] [Abstract][Full Text] [Related]
3. The morphologic spectrum of kidney tumors in hereditary leiomyomatosis and renal cell carcinoma (HLRCC) syndrome.
Merino MJ; Torres-Cabala C; Pinto P; Linehan WM
Am J Surg Pathol; 2007 Oct; 31(10):1578-85. PubMed ID: 17895761
[TBL] [Abstract][Full Text] [Related]
4. Novel FH mutations in families with hereditary leiomyomatosis and renal cell cancer (HLRCC) and patients with isolated type 2 papillary renal cell carcinoma.
Gardie B; Remenieras A; Kattygnarath D; Bombled J; Lefèvre S; Perrier-Trudova V; Rustin P; Barrois M; Slama A; Avril MF; Bessis D; Caron O; Caux F; Collignon P; Coupier I; Cremin C; Dollfus H; Dugast C; Escudier B; Faivre L; Field M; Gilbert-Dussardier B; Janin N; Leport Y; Leroux D; Lipsker D; Malthieu F; McGilliwray B; Maugard C; Méjean A; Mortemousque I; Plessis G; Poppe B; Pruvost-Balland C; Rooker S; Roume J; Soufir N; Steinraths M; Tan MH; Théodore C; Thomas L; Vabres P; Van Glabeke E; Meric JB; Verkarre V; Lenoir G; Joulin V; Deveaux S; Cusin V; Feunteun J; Teh BT; Bressac-de Paillerets B; Richard S;
J Med Genet; 2011 Apr; 48(4):226-34. PubMed ID: 21398687
[TBL] [Abstract][Full Text] [Related]
5. The syndrome of hereditary leiomyomatosis and renal cell cancer (HLRCC): The clinical features of an individual with a fumarate hydratase gene mutation.
Varol A; Stapleton K; Roscioli T
Australas J Dermatol; 2006 Nov; 47(4):274-6. PubMed ID: 17034471
[TBL] [Abstract][Full Text] [Related]
6. Conventional renal cancer in a patient with fumarate hydratase mutation.
Lehtonen HJ; Blanco I; Piulats JM; Herva R; Launonen V; Aaltonen LA
Hum Pathol; 2007 May; 38(5):793-6. PubMed ID: 17270241
[TBL] [Abstract][Full Text] [Related]
7. Renal tubulocystic carcinoma is closely related to papillary renal cell carcinoma: implications for pathologic classification.
Zhou M; Yang XJ; Lopez JI; Shah RB; Hes O; Shen SS; Li R; Yang Y; Lin F; Elson P; Sercia L; Magi-Galluzzi C; Tubbs R
Am J Surg Pathol; 2009 Dec; 33(12):1840-9. PubMed ID: 19898225
[TBL] [Abstract][Full Text] [Related]
8. Hereditary leiomyomatosis and renal cell cancer: an unusual and aggressive form of hereditary renal carcinoma.
Refae MA; Wong N; Patenaude F; Bégin LR; Foulkes WD
Nat Clin Pract Oncol; 2007 Apr; 4(4):256-61. PubMed ID: 17392716
[TBL] [Abstract][Full Text] [Related]
9. Mechanisms of disease: hereditary leiomyomatosis and renal cell cancer--a distinct form of hereditary kidney cancer.
Sudarshan S; Pinto PA; Neckers L; Linehan WM
Nat Clin Pract Urol; 2007 Feb; 4(2):104-10. PubMed ID: 17287871
[TBL] [Abstract][Full Text] [Related]
10. Hereditary leiomyomatosis and renal cell cancer in families referred for fumarate hydratase germline mutation analysis.
Smit DL; Mensenkamp AR; Badeloe S; Breuning MH; Simon ME; van Spaendonck KY; Aalfs CM; Post JG; Shanley S; Krapels IP; Hoefsloot LH; van Moorselaar RJ; Starink TM; Bayley JP; Frank J; van Steensel MA; Menko FH
Clin Genet; 2011 Jan; 79(1):49-59. PubMed ID: 20618355
[TBL] [Abstract][Full Text] [Related]
11. Evidence for a founder effect of the germline fumarate hydratase gene mutation R58P causing hereditary leiomyomatosis and renal cell cancer (HLRCC).
Heinritz W; Paasch U; Sticherling M; Wittekind C; Simon JC; Froster UG; Renner R
Ann Hum Genet; 2008 Jan; 72(Pt 1):35-40. PubMed ID: 17908262
[TBL] [Abstract][Full Text] [Related]
12. Comparison of DNA gains and losses in primary renal clear cell carcinomas and metastatic sites: importance of 1q and 3p copy number changes in metastatic events.
Gronwald J; Störkel S; Holtgreve-Grez H; Hadaczek P; Brinkschmidt C; Jauch A; Lubinski J; Cremer T
Cancer Res; 1997 Feb; 57(3):481-7. PubMed ID: 9012478
[TBL] [Abstract][Full Text] [Related]
13. Morphologic features of uterine leiomyomas associated with hereditary leiomyomatosis and renal cell carcinoma syndrome: a case report.
Garg K; Tickoo SK; Soslow RA; Reuter VE
Am J Surg Pathol; 2011 Aug; 35(8):1235-7. PubMed ID: 21753700
[TBL] [Abstract][Full Text] [Related]
14. [From gene to disease; cutaneous leiomyomatosis].
Badeloe S; van Geel M; van Steensel MA; Steijlen PM; Poblete-Gutiérrez P; Frank JA
Ned Tijdschr Geneeskd; 2007 Feb; 151(5):300-4. PubMed ID: 17326474
[TBL] [Abstract][Full Text] [Related]
15. Inherited susceptibility to uterine leiomyomas and renal cell cancer.
Launonen V; Vierimaa O; Kiuru M; Isola J; Roth S; Pukkala E; Sistonen P; Herva R; Aaltonen LA
Proc Natl Acad Sci U S A; 2001 Mar; 98(6):3387-92. PubMed ID: 11248088
[TBL] [Abstract][Full Text] [Related]
16. Familial cutaneous leiomyomatosis is a two-hit condition associated with renal cell cancer of characteristic histopathology.
Kiuru M; Launonen V; Hietala M; Aittomäki K; Vierimaa O; Salovaara R; Arola J; Pukkala E; Sistonen P; Herva R; Aaltonen LA
Am J Pathol; 2001 Sep; 159(3):825-9. PubMed ID: 11549574
[TBL] [Abstract][Full Text] [Related]
17. A novel missense mutation in fumarate hydratase in an Italian patient with a diffuse variant of cutaneous leiomyomatosis (Reed's syndrome).
Rongioletti F; Fausti V; Ferrando B; Parodi A; Mandich P; Pasini B
Dermatology; 2010; 221(4):378-80. PubMed ID: 21051878
[TBL] [Abstract][Full Text] [Related]
18. Clinical and molecular genetic aspects of hereditary multiple cutaneous leiomyomatosis.
Badeloe S; Frank J
Eur J Dermatol; 2009; 19(6):545-51. PubMed ID: 19939761
[TBL] [Abstract][Full Text] [Related]
19. [Hereditary leiomyomatosis and renal cell cancer - HLRCC/multiple cutaneous and uterine leimomyomatosis - MCUL].
Plevová P; Hladíková A; Tesařová M
Klin Onkol; 2012; 25 Suppl():S55-8. PubMed ID: 22920208
[TBL] [Abstract][Full Text] [Related]
20. High-resolution analysis of DNA copy number alterations and gene expression in renal clear cell carcinoma.
Yoshimoto T; Matsuura K; Karnan S; Tagawa H; Nakada C; Tanigawa M; Tsukamoto Y; Uchida T; Kashima K; Akizuki S; Takeuchi I; Sato F; Mimata H; Seto M; Moriyama M
J Pathol; 2007 Dec; 213(4):392-401. PubMed ID: 17922474
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]